Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

Free Radical Biology and Medicine

Volumn 30, Issue 1, 2001, Pages 119-128

  Kontush, Anatol ^a   Berndt, Christine ^a   Weber, Wilfried ^a   Akopyan, Violetta ^a   Arlt, Sönke ^a   Schippling, Sven ^a   Beisiegel, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alzheimer's disease; Amyloid ; Antioxidant; Cerebrospinal fluid; Free radicals; Lipoproteins; Oxidation; Plasma

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; COPPER; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METAL ION;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOOXIDATION; BODY FLUID; CATALYSIS; CEREBROSPINAL FLUID; CHELATION; CONTROLLED STUDY; HUMAN; LIPOPROTEIN BLOOD LEVEL; OXIDATION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SENILE PLAQUE;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIOXIDANTS; CHOLESTEROL; COPPER; HUMANS; HYDROGEN PEROXIDE; KINETICS; LINOLEIC ACID; LIPID PEROXIDATION; LIPOPROTEINS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS;

EID: 0035178803     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00458-5     Document Type: Article

References (54)

1. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease
2. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease
3. Oxidative stress hypothesis in Alzheimer's disease
4. Oxidative mechanisms in beta-amyloid cytotoxicity
5. Reactive oxygen species and Alzheimer's disease
6. Radical AGEing in Alzheimer's disease
7. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease
8. Normal and abnormal biology of the beta-amyloid precursor protein
9. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease
10. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
11. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins
12. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma
13. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma
14. Processing of amyloid precursor protein in human primary neuron and astrocyte cultures
15. Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein
16. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth
17. Physiological levels of beta-amyloid peptide promote PC12 cell proliferation
18. Physiological levels of beta-amyloid peptide stimulate protein kinase C in PC12 cells
19. Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions
20. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide
21. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis
22. Alzheimer's beta-amyloid peptide: Affinity for metal chelates
23. Low density lipoprotein oxidation and its pathobiological significance
24. The composition of lipids in cerebrospinal fluid of children and adults
25. Central nervous system lipoproteins in Alzheimer's disease
26. Lipoprotein oxidation and Alzheimer's disease
27. Time-course of oxidation of lipids in human cerebrospinal fluid in vitro
28. Increased lipoprotein oxidation in Alzheimer's disease
29. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo
30. Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing
31. Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins
32. Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia
33. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: The role of alpha-carotene and gamma-tocopherol
34. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper
35. Continuous monitoring of in vitro oxidation of human low density lipoprotein
36. Measurement of oxidizability of blood plasma
37. Diffuse plaques contain C-terminal A beta 42 and not A beta 40: Evidence from cats and dogs
38. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells
39. Use of ascorbate as test for catalytic metals in simple buffers
40. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
41. Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid
42. Two step protocol for Alzheimer's soluble amyloid beta protein isolation from normal cerebrospinal fluid lipoprotein
43. Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes
44. The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 42, apolipoprotein E and transthyretin in human cerebrospinal fluid
45. Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease
46. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance
47. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
48. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type - Place of the extracellular glutathione peroxidase
49. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells
50. Copper, iron and zinc in Alzheimer's disease senile plaques
51. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of A-beta by zinc
52. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome
53. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice